rymti solution
lupin pharma canada limited - Étanercept - solution - 50mg - Étanercept 50mg
kineret solution
swedish orphan biovitrum ab (publ) - anakinra - solution - 150mg - anakinra 150mg - disease-modifying antirheumatic agents
humira solution
abbvie corporation - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
humira solution
abbvie corporation - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
humira solution
abbvie corporation - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
stelara i.v. solution
janssen inc - ustékinumab - solution - 5mg - ustékinumab 5mg - misc. skin and mucous membrane agents
ilaris solution
novartis pharmaceuticals canada inc - canakinumab - solution - 150mg - canakinumab 150mg - immunosuppressive agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 150mg - sarilumab 150mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents
orencia solution
bristol-myers squibb canada - abatacept - solution - 125mg - abatacept 125mg - immunosuppressive agents